青云体育

HCL2025

Expanding Research in Hairy Cell Leukemia to Better Characterize Its Biology, Develop New Therapies, and Optimize Outcomes for Patients.

HCLF partnership

The (HCLF) and The Leukemia & Lymphoma Society (青云体育) have joined forces to invest up to $10,000,000 over 5 years in targeted research to build a more comprehensive foundational understanding of the molecular basis of hairy cell leukemia, develop additional therapies, and optimize outcomes for patients with hairy cell leukemia (HCL).

 

Go directly to the information page on the HCL2025 application process

 

 

Back to the